An in-vitro assay booking should begin with a documented material, not a hopeful assumption. Before a plate is scheduled, a vial is brought to room temperature or a reagent is prepared, the laboratory needs a clean trace from the catalogue SKU and the expiry reference on the label through to the correct Certificate of Analysis (CoA). Research Sciences supplies research-use-only (RUO) peptides, laboratory accessories and preparation tools for controlled in-vitro scientific research. Its materials are not for human or veterinary use, and are not medicines, medical devices, treatments or food supplements under UK law. That compliance position matters because traceability is not administrative decoration: it is the evidence that the material on the bench is the material described in the protocol, within its stated handling window, and supported by the batch documentation held on file.
Start at the Vial Label: SKU, Expiry Reference and the Batch Trail
The first practical checkpoint is the vial label. Research Sciences describes a label reference format that combines the SKU code and expiry date, for example BPC10-03/27, linking that reference to the corresponding CoA. For a materials manager or laboratory researcher, this reference should be treated as the primary key in the traceability chain. It should be checked against the order confirmation, the catalogue entry and the CoA file before any new in-vitro assay is booked. A mismatch at this stage is not a minor clerical issue; it is a reason to pause bench work and clarify the documentation with the supplier using the quoted vial reference.
The SKU locates the item within the catalogue, while the expiry reference constrains when the material may be suitable for controlled laboratory use. Neither should be copied from an old worksheet without verification, particularly where a laboratory holds several vials from different deliveries. Packaging may vary between batches, and vial cap colours or other visual details should not be used as indicators of identity, analytical quality or manufacturing origin. The label reference and accompanying documentation carry the evidential weight.
Restocks require particular care. The Research Sciences FAQs note that restocked products may carry the same Internal Test Reference (ITR) as earlier stock. An ITR links to associated sample testing reports, but it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. A laboratory should therefore avoid treating an ITR as a substitute for the batch CoA that accompanies the material being used. Older pages and posts may still refer to Imperial Sciences UK or Imperial Peptides UK; the FAQs describe Research Sciences as the parent company of Imperial Peptides UK, with Imperial Peptides UK continuing as a brand. For traceability, the current shop name, the vial reference and the batch document should be matched together rather than relying on a historical brand name alone. Once the label is checked, the CoA becomes the second link in the chain.
Read the CoA as a Batch Document, Not a Catalogue Badge
A CoA is most useful when it is read as a batch-specific document. Research Sciences states that products include a CoA for purity and identity by HPLC, and its wider testing framework describes purity, identity, heavy metals and endotoxin evaluation of submitted samples, alongside CoA documentation. The homepage also lists “CoAs Janoshik Analytical Reports”. These are the shop’s published descriptions and should be reconfirmed on the live site and, more importantly, against the CoA that accompanies the specific batch. A catalogue-level claim is not a substitute for opening the document linked to the vial in hand.
Before an in-vitro assay is booked, the researcher should confirm that the CoA file matches the product name, SKU and label reference, and that the batch or ITR details are consistent with the material received. The exact purity, identity information and any reported contaminant screening should be taken from that batch CoA rather than from a general product page. Published headline figures such as “≥99% Verified Purity” or “Over 99.1% Purity” are the shop’s current published wording; they should not be treated as a single reconciled result for every vial. Where purity is relevant to assay design, the batch CoA is the document to check and retain.
The CoA should also be filed in a way that supports laboratory governance. A practical record might include the SKU, expiry reference, ITR or batch reference, CoA file name or version, date accessed, storage condition at receipt and the name of the person who verified the match. This is especially important where a laboratory orders the same catalogue item more than once. A CoA from an earlier delivery should not be assumed to cover a later vial simply because the product name is unchanged. If a document cannot be matched confidently, the safest course is to escalate the discrepancy before booking the assay, rather than allowing the uncertainty to enter the experimental record.
Booking the In-Vitro Assay: Evidence Checkpoints Before Bench Work
With the label and CoA checked, the final traceability step is to link the material record to the assay booking. The researcher and materials manager should be able to answer four questions before the work is scheduled: which SKU is being used, which expiry reference appears on the vial, which CoA file supports that batch, and where those records are stored. Where a repeat order is being planned, compare the live catalogue listing at Peptides uk with the order confirmation and the batch CoA, then file any discrepancy against the quoted vial reference. This keeps procurement, receipt and laboratory use within one auditable sequence.
Handling records should sit alongside that sequence. Research Sciences’ research-use guidance describes allowing vials to reach room temperature before opening, working in a clean environment, removing only the amount required for the experiment, and storing lyophilised peptides at –20°C or below, sealed with desiccant and protected from moisture, heat and light. Repeated freeze–thaw cycles should be avoided. Reconstituted peptides are described as less stable and should be stored at 2–8°C for short-term laboratory use. Any reconstitution for an in-vitro assay should be planned as a laboratory workflow step, with diluent volume and target concentration recorded for the assay; the shop’s materials and any reconstitution calculator are for laboratory research use only and must not be used for human or veterinary use.
Fulfilment information can support receipt records but should not be confused with analytical traceability. Current published terms describe next-working-day dispatch and Royal Mail Tracked 24, which usually delivers the following working day as a Royal Mail estimate; tracking is provided after dispatch, and delivery times may vary. Those terms should be reconfirmed at checkout. The assay booking itself should rest on the verified SKU, expiry reference, matching CoA and documented storage history. Materials remain research-use-only, not for human or veterinary use, and the purchaser remains responsible for lawful use, safe handling, storage, disposal, COSHH and laboratory safety. Only when those checkpoints are complete should the in-vitro assay be placed on the schedule.